Breaking News, Collaborations & Alliances

Phillips-Medisize and Exact Sciences Partner to Advance Early Cancer Detection

End-to-end manufacturing ensures patient-focused product design, supply chain optimization and diversified production to speed time to market and reduce risk.

Author Image

By: Charlie Sternberg

Associate Editor

Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, has completed a successful collaboration with Exact Sciences, a leader in cancer diagnostics, to advance early cancer detection.   Fueled by a relentless pursuit for smarter, earlier life-changing answers about cancer, Exact Sciences developed Cologuard, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. This mission aligned seamlessly with Phillips-Medisize’...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters